1 to 3 of 3 literature results

• Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2.

  Adipocyte fatty-acid-binding protein, aP2 (FABP4) is expressed in adipocytes and macrophages, and integrates inflammatory and metabolic responses. Stu…

  Authors: Masato Furuhashi, Gürol Tuncman, Cem Z Görgün, Liza Makowski, Genichi Atsumi, Eric Vaillancourt, Keita Kono, Vladimir R Babaev, Sergio Fazio, MacRae F Linton,…

  Source: Nature. 2007 Jun 21

  View Full Text

• Role of the fatty acid binding protein mal1 in obesity and insulin resistance.

  The metabolic syndrome is a cluster of metabolic and inflammatory abnormalities including obesity, insulin resistance, type 2 diabetes, hypertension, …

  Authors: Kazuhisa Maeda, K Teoman Uysal, Liza Makowski, Cem Z Görgün, Genichi Atsumi, Rex A Parker, Jens Brüning, Ann Vogel Hertzel, David A Bernlohr, Gökhan S Hotamisligil

  Source: Diabetes. 2003 Feb

  View Full Text

• Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes.

  Fatty acid binding proteins (FABPs) are cytosolic fatty acid chaperones whose biological role and mechanisms of action are not well understood. Here, …

  Authors: Kazuhisa Maeda, Haiming Cao, Keita Kono, Cem Z Gorgun, Masato Furuhashi, Kadir T Uysal, Qiong Cao, Genichi Atsumi, Harry Malone, Bala Krishnan,…

  Source: Cell metabolism. 2005 Feb

  View Full Text